The role of beta cell regeneration in type 2 diabetes

October 10, 2012
The role of beta cell regeneration in type 2 diabetes
Credit: Thinkstock

The World Health Organization (WHO) has declared type 2 diabetes as the epidemic of the 21st century. A study is focusing on understanding the mechanisms underlying insulin resistance and the role of beta-cell regeneration.

Type 2 diabetes develops through a step-wise process, starting by the inability of the body to use insulin effectively which causes to produce more insulin in an attempt to compensate for this phenomenon. Eventually, the beta cells become exhausted and cannot produce enough insulin to overcome and at this point, this condition can progress to diabetes.

A substantial decrease in the number of beta cells due to extensive cell death or decreased proliferation, and/or an impairment of are considered the most likely mechanisms underlying type 2 diabetes. The European BCELL-T2D is aiming to delineate these mechanisms and study the potential of beta- in therapy.

To achieve this, scientists have characterised a mouse model carrying a mutation in the receptor that binds the fat cell-specific hormone leptin. These animals are prone to obesity and type 2 diabetes.

Results so far indicate that insulin resistance starts at 4–9 weeks of age, progresses to frank diabetes (10–18 weeks of age) and finally to advanced diabetes and its complications (after 19 weeks of age). Assessment of the beta-cell mass at each stage has shown an initial expansion in the insulin compensatory phase that disappears along the evolution of the disease.

As a therapeutic intervention, scientists are looking to overcome the proliferation shortage of beta cells by providing cyclin C, a protein that controls cell cycle entry. Ongoing research will determine if sustained beta- has the potential to prevent diabetes debut.

By studying the type 2 diabetes mouse model, scientists have revealed novel insight into the disease development and pathophysiology. Project findings hold great potential of being translated into new therapies in order to prevent and treat this devastating disease and its complications.

Explore further: Researchers find beta cell stress could trigger the development of type 1 diabetes

Related Stories

Researchers find beta cell stress could trigger the development of type 1 diabetes

March 22, 2012
In type 1 diabetes (T1D), pancreatic beta cells die from a misguided autoimmune attack, but how and why that happens is still unclear. Now, JDRF-funded scientists from the Indiana University School of Medicine have found ...

Insulin signaling is distorted in pancreases of Type 2 diabetics

December 13, 2011
Insulin signaling is altered in the pancreas, a new study shows for the first time in humans. The errant signals disrupt both the number and quality of beta cells — the cells that produce insulin.

Connexins: Providing protection to cells destroyed in Type 1 diabetes

November 7, 2011
Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone ...

Hormone discovered that preserves insulin production and beta cell function in diabetes

July 2, 2012
(Medical Xpress) -- Researchers at Duke University Medical Center have found protective, anti-diabetic functions for a hormone that, like insulin, is produced by the islet cells of the pancreas. The new hormone was found ...

Recommended for you

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

Online team-based game helps patients with diabetes lower blood glucose

August 8, 2017
Researchers from Brigham and Women's Hospital and the Veterans Affairs Boston Healthcare System have found that an online, team-based game designed to teach patients about diabetes self-management had a sustained and meaningful ...

Oxidative stress biomarkers don't always signal diabetes risk

August 7, 2017
High levels of compounds found in the body that are commonly associated with oxidative damage may actually be a good sign for some people, according to a recent review of multiple human studies led by an epidemiologist at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.